Versant Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.01M Buy
5,432
+281
+5% +$52.2K 0.15% 77
2025
Q1
$1.08M Buy
5,151
+2,416
+88% +$506K 0.18% 69
2024
Q4
$486K Buy
2,735
+693
+34% +$123K 0.1% 97
2024
Q3
$403K Buy
2,042
+616
+43% +$122K 0.09% 95
2024
Q2
$245K Sell
1,426
-104
-7% -$17.8K 0.06% 124
2024
Q1
$279K Sell
1,530
-696
-31% -$127K 0.08% 103
2023
Q4
$345K Sell
2,226
-17
-0.8% -$2.63K 0.1% 86
2023
Q3
$334K Buy
2,243
+33
+1% +$4.92K 0.11% 86
2023
Q2
$298K Sell
2,210
-9
-0.4% -$1.21K 0.1% 96
2023
Q1
$354K Buy
2,219
+57
+3% +$9.08K 0.12% 83
2022
Q4
$349K Buy
2,162
+10
+0.5% +$1.62K 0.13% 78
2022
Q3
$289K Buy
2,152
+47
+2% +$6.31K 0.11% 81
2022
Q2
$322K Buy
2,105
+4
+0.2% +$612 0.12% 81
2022
Q1
$341K Buy
2,101
+6
+0.3% +$974 0.11% 84
2021
Q4
$284K Buy
2,095
+118
+6% +$16K 0.09% 89
2021
Q3
$213K Buy
1,977
+230
+13% +$24.8K 0.08% 93
2021
Q2
$197K Buy
1,747
+27
+2% +$3.05K 0.07% 94
2021
Q1
$186K Buy
1,720
+517
+43% +$55.9K 0.07% 106
2020
Q4
$128K Sell
1,203
-1,913
-61% -$204K 0.05% 127
2020
Q3
$272K Buy
3,116
+11
+0.4% +$960 0.12% 81
2020
Q2
$304K Buy
3,105
+41
+1% +$4.01K 0.14% 71
2020
Q1
$233K Buy
3,064
+144
+5% +$11K 0.12% 75
2019
Q4
$258K Sell
2,920
-36
-1% -$3.18K 0.13% 68
2019
Q3
$223K Sell
2,956
-184
-6% -$13.9K 0.1% 77
2019
Q2
$228K Sell
3,140
-319
-9% -$23.2K 0.1% 82
2019
Q1
$278K Sell
3,459
-373
-10% -$30K 0.12% 74
2018
Q4
$353K Hold
3,832
0.16% 64
2018
Q3
$362K Sell
3,832
-82
-2% -$7.75K 0.15% 64
2018
Q2
$362K Sell
3,914
-18
-0.5% -$1.67K 0.15% 69
2018
Q1
$372K Sell
3,932
-146
-4% -$13.8K 0.15% 69
2017
Q4
$394K Buy
4,078
+304
+8% +$29.4K 0.16% 73
2017
Q3
$335K Hold
3,774
0.18% 55
2017
Q2
$273K Buy
3,774
+10
+0.3% +$723 0.15% 60
2017
Q1
$245K Hold
3,764
0.14% 64
2016
Q4
$235K Sell
3,764
-14
-0.4% -$874 0.13% 64
2016
Q3
$238K Sell
3,778
-28
-0.7% -$1.76K 0.14% 69
2016
Q2
$235K Sell
3,806
-37
-1% -$2.29K 0.14% 64
2016
Q1
$219K Sell
3,843
-26
-0.7% -$1.48K 0.13% 65
2015
Q4
$229K Buy
+3,869
New +$229K 0.14% 61